NAVIGATOR Steers Uncontrolled Asthma Toward Calmer Seas NAVIGATOR Steers Uncontrolled Asthma Toward Calmer Seas
The phase 3 trial showed high complete response rates and reduced disease burden with tezepelumab vs placebo.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 18, 2022 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news

Here's What Happened to Asthma, COPD Admissions After a Big Polluter Shut Down
(MedPage Today) -- SAN FRANCISCO -- For neighborhoods near a major coking operation in Pittsburgh, its shutdown at the end of 2015 was followed by markedly lower rates of respiratory disease hospitalizations, researchers reported here. Inpatient... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 18, 2022 Category: Allergy & Immunology Source Type: news

Asthma, Allergies Raise Heart Risks, Too
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 18, 2022 Category: Respiratory Medicine Tags: Cardiology, Pharmacy, Pulmonology, Allergy, News, Source Type: news

New Data Show TREMFYA ® (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab
SPRING HOUSE, PENNSYLVANIA, May 18, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first results of the in vitro MODIF-Y studies, supporting a hypothesis that may differentiate the mechanism of first-in-class TREMFYA® (guselkumab) from risankizumab due to the ability of TREMFYA to bind to CD64 positive (CD64+) cells in addition to interleukin (IL)-23 — both of which are key components of the immune system. 1,2 These findings, which are being presented at the Society for Investigative Dermatology (SID) annual meeting May 18-21, 2022 in Portland, Oregon, demonstrate TREMFYA bind...
Source: Johnson and Johnson - May 18, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Janssen Campaign Developed by and for the LGBTQ+ Community Inspires Action and Empathy for People Living with Depression
TITUSVILLE, NJ, May 18, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Depression Looks Like Me, a campaign aimed at normalizing the conversation about depression in the LGBTQ+ community and empowering people to seek the mental health care they may need. Janssen has partnered with prominent LGBTQ+ voices and leading mental health and LGBTQ+ advocacy organizations to amplify lived experiences across the community and underscore that those living with hard-to-treat depression are not alone. Depression is a serious and chronic health condition that disproportionally affect...
Source: Johnson and Johnson - May 18, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Regulatory approval of Spikevax (formerly COVID-19 Vaccine Moderna), MHRA (updated 18th May 2022)
Information for healthcare professionals and the public about Spikevax 18 May 2022This is a change to the Summary of Product Characteristics to allow for third dose heterologous boosting (i.e. someone having a different vaccine to their primary course as a booster) and shorten the interval between the primary course and booster dose from at least 6 months to at least 3 months. The patient information leaflet has not been changed. 5 May 2022The website decision page for the mRNA COVID-19 vaccines has been updated to reflect the fact that the 15-minute observation period following vaccination has been removed for indiv...
Source: Current Awareness Service for Health (CASH) - May 18, 2022 Category: Consumer Health News Source Type: news

Pret allergy death: Natasha Ednan-Laperouse's parents set up trial
The trial has been set up by the family of Natasha Ednan-Laperouse, who died after eating a sandwich. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 18, 2022 Category: Consumer Health News Source Type: news

Albuterol-Budesonide Combo Offers Better Rescue Therapy for Moderate to Severe Asthma Albuterol-Budesonide Combo Offers Better Rescue Therapy for Moderate to Severe Asthma
Among patients with uncontrolled moderate to severe asthma, a fixed-dose combination of albuterol and budesonide gives better as-needed relief than albuterol alone, a large international study shows.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 17, 2022 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news

Achoo! The hay fever season lasts longer than ever. Here ’s what we can do about it | Kate Ravilious
The climate crisis is giving trees a bigger window to spread their pollen, but cleaner air and better early warning forecasts can help protect usIf you have sneezed your way through the last few days, you are not alone. About aquarter of the UK population are thought to suffer from hay fever, with numbers continuing to grow. And thelatest researchsuggests that the climate crisis is going to make the hay fever season a whole lot longer and more intense, with up to three times as much pollen wafting around by the end of the century. Hold on to your antihistamines.For people with lung conditions such as asthma or chronic obst...
Source: Guardian Unlimited Science - May 17, 2022 Category: Science Authors: Kate Ravilious Tags: Hay fever Climate crisis Environment Allergies Society Source Type: news

Writing Out Common Medical Terms Boosts Patient Knowledge: Study Writing Out Common Medical Terms Boosts Patient Knowledge: Study
Research published in JAMA Network Open shows that patients are more likely to understand their health conditions when healthcare providers avoid abbreviations and acronyms in written communications.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 16, 2022 Category: Allergy & Immunology Tags: Family Medicine/Primary Care News Source Type: news

Eye health tips for high pollen levels
As pollen levels rise and many people across the UK start experiencing hay fever symptoms, The College of Optometrists has issued new member resources and eye health tips to help the public manage their allergies. (Source: NHS Networks)
Source: NHS Networks - May 16, 2022 Category: UK Health Source Type: news

Two Drugs Better Than One for 'Rescue' Asthma Therapy
(MedPage Today) -- SAN FRANCISCO -- Phase III results look very good for a two-drug combination inhaler in helping asthma patients regain symptom control when maintenance medications weren't doing the job. In the MANDALA trial, patients using... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 15, 2022 Category: Allergy & Immunology Source Type: news

ECMO for COVID; Heart Attack Treatment in High-Income Countries; Screen for COPD?
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 14, 2022 Category: Allergy & Immunology Source Type: news

Covid variant warning: Why UK plans may leave public 'somewhat exposed' to virus mutations
THE GOVERNMENT is to cut more than 800 jobs from its flagship public health body and suspend asymptomatic Covid testing in some settings. But, an immunologist has warned that removing coronavirus tests for the most vulnerable could leave the UK exposed to new variants. (Source: Daily Express - Health)
Source: Daily Express - Health - May 14, 2022 Category: Consumer Health News Source Type: news

Are Physician White Coats Becoming Obsolete? Are Physician White Coats Becoming Obsolete?
The white coat has been the traditional physician garb. But since the pandemic, more have been wearing scrubs or more casual clothing. What ' s best for physicians to wear?Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 13, 2022 Category: Allergy & Immunology Tags: Internal Medicine News Source Type: news